CPSI, a healthcare solutions company, today announced that it has acquired Healthcare Resource Group, Inc. (“HRG”). Based in Spokane, Washington, HRG is a leading provider of customized revenue cycle management (“RCM”) solutions and consulting services that enable hospitals and clinics to improve efficiency, profitability, and patient satisfaction. Founded in 1994, HRG has approximately 400 employees, serving 77 healthcare clients, primarily located in the Pacific Nort

UniDoc Health Corp. an innovator in the telehealth sector, is pleased to provide certain background information regarding a commercial licensing agreement with Dedalus S.p.A. (“Dedalus Group” or “Dedalus”), a global health software company founded in Italy and headquartered in Florence, Tuscany. The relationship between UniCheck SRL (a UniDoc affiliate) as licensee and Dedalus as licensor encompass the development and provisioning of the technological backbon

 Forescout Technologies, the leader in Active Defense for the Enterprise of Things, today announced its acquisition of CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks. The acquisition further strengthens Forescout’s position as the industry leader in out-of-the-box support for the broadest set of connected device types across IT, IoT, OT and IoMT devices. “Forescout is seeing

Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, announced today a multi-year agreement with UCI Health to support continuous artificial intelligence (AI)-powered remote monitoring of acute and post-acute care patients in their homes through Biofourmis tools. UCI Health comprises the clinical enterprise of the University of California, Irvine and is Orange County's only academic health system. The medical

Masimo announced today the FDA clearance of SedLine® brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the potential benefits of SedLine have been expanded to all patients one year old and above in the United States. Equipped with Masimo’s advanced signal processing technology, SedLine helps clinicians monitor brain activity bilaterally by processing electroencephalogram (EEG) signals from Masimo’s f

Lagos based international health and hospitality brands- Duchess International Hospital and The Lagos Marriot Hotel  have come together to pioneer the first ever three-day comprehensive medical screening and disease prevention services in Nigeria. Known as the Duchess Royal Medical Check Up, it is a premium executive health check programme aimed at promoting affordable access to health and preventing the onset of chronic diseases. Speaking at the launch of the programme in Lago

Lagos based international health and hospitality brands- Duchess International Hospital and The Lagos Marriot Hotel  have come together to pioneer the first ever three-day comprehensive medical screening and disease prevention services in Nigeria. Known as the Duchess Royal Medical Check Up, it is a premium executive health check programme aimed at promoting affordable access to health and preventing the onset of chronic diseases. Speaking at the launch of the programme in Lago

Encompass Health Corp. and Lee Healthcare Holdings, LLC, wholly owned subsidiary of Lee Health, today announced a collaboration to jointly own and operate two new inpatient rehabilitation hospitals in Southwest Florida. Recently, the Board of Directors of Lee Health approved its investment in this collaboration with Encompass Health. One of the hospitals will be a 40-bed, freestanding inpatient rehabilitation hospital currently under construction in Cape Coral at 1730 NE Pine Island

Privately-held insurance brokerage firm As One Insurance Group ("As One") has announced the launch of its population health strategy that is already revolutionizing the healthcare industry - based in Phoenix, As One has quickly achieved benchmark status in the population health world.  Brandon Bullock, Chief Strategy Officer of As One, says, "Over the years we have seen the number of those without access to healthcare shrink, the numbers are a positive sign, 10 p

LivaNova PLC , a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study, “Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation” (OSPREY). The randomized controlled trial (RCT) seeks to demonstrate the safety and effectiveness of the LivaNova aura6000™ System, an implantable hypoglossal neurostimulator intended to treat adult patients with modera